Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Shutting down Wnt signal–activated cancer

Nature Genetics volume 36, pages 320–322 (2004)Cite this article

New evidence suggests that Wnt signaling can be suppressed or further activated by upstream signals, even though the pathway seems to be constitutively activated by downstream mutations in cancer cells.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Quantitative control of the canonical Wnt pathway.

References

  1. Giles, R.H., van Es, J.H. & Clevers, H. Biochim. Biophys. Acta 1653, 1–24 (2003).

    CAS  PubMed  Google Scholar 

  2. Veeman, M.T., Axelrod, J.D. & Moon, R.T. Dev. Cell 5, 367–377 (2003).

    Article  CAS  Google Scholar 

  3. Suzuki, H. et al. Nat. Genet. 36, 417–422 (2004).

    Article  CAS  Google Scholar 

  4. Suzuki, H. et al. Nat. Genet. 31, 141–149 (2002).

    Article  CAS  Google Scholar 

  5. Wang, Z., Vogelstein, B. & Kinzler, K.W. Cancer Res. 63, 5243–5245 (2003).

    Google Scholar 

  6. Liu, C. et al. Cell 108, 837–847 (2002).

    Article  CAS  Google Scholar 

  7. Amit, S. et al. Genes Dev. 16, 1066–1076 (2002).

    Article  CAS  Google Scholar 

  8. Chan, T.A., Wang, Z., Dang, L.H., Vogelstein, B. & Kinzler, K.W. Proc. Natl. Acad. Sci. USA 99, 8265–8270 (2002).

    Article  CAS  Google Scholar 

  9. Sparks, A.B., Morin, P.J., Vogelstein, B. & Kinzler, K.W. Cancer Res. 58, 1130–1134 (1998).

    CAS  PubMed  Google Scholar 

  10. Morin, P.J. et al. Science 275, 1787–1790 (1997).

    Article  CAS  Google Scholar 

  11. Ilyas, M., Tomlinson, I.P.M., Rowan, A., Pignatelli, M. & Bodmer, W.F. Proc. Natl. Acad. Sci. USA 94, 10330–10334 (1997).

    Article  CAS  Google Scholar 

  12. Hart, M.J., de los Santos, R., Albert, I.N., Rubinfeld, B. & Polakis, P. Curr. Biol. 8, 573–581 (1998).

    Article  CAS  Google Scholar 

  13. Wehri, M. et al. Nature 407, 527–530 (2000).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Kyoto University School of Medicine, Kyoto, Japan

    M Mark Taketo

Authors
  1. M Mark Taketo
    View author publications

    You can also search for this author inPubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taketo, M. Shutting down Wnt signal–activated cancer. Nat Genet 36, 320–322 (2004). https://doi.org/10.1038/ng0404-320

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng0404-320

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing